Given its dual role, targeting TNF-α in cancer therapy is complex. Some therapeutic strategies aim to inhibit TNF-α to reduce inflammation and tumor growth, while others use TNF-α or its derivatives to induce tumor cell apoptosis. Anti-TNF-α antibodies and small molecule inhibitors are some of the approaches to block TNF-α activity in cancer.
